Related Experiment Video
Updated: Aug 30, 2026
Studying TGF-β Signaling and TGF-β-induced Epithelial-to-mesenchymal Transition in Breast Cancer and Normal Cells
Published on: October 27, 2020
[Studies of TGF-beta/Smads expression in lung cancer]
Jing-Ling Shen1, Cheng-Hui Yan, Yan Liu
1Department of Medical Genetics, Harbin Medical University, Harbin 150086, China.
Abstract:
Smad proteins transduce signals from transforming growth factor beta superfamily ligands that regulate cell proliferation, differentiation and death through activation of receptor serine/threonine kinases. TGF-beta/Smads signal pathway not only has transforming potential but can also drive tumourigenesis, malignant progression, invasion and metastasis of human cancers. Using the immuno-histochemistry, we investigate the expression and location of TGF-beta R II, Smad2, Smad4 and Smad7 in 20 lung cancer specimens and 8 lung cancer cell lines. The results suggest that aberrant smads protein expression is significantly related to lung cancer tumoruigenesis and progression. Interestingly, TGF-beta R II and Smad7 strongly express in high metastasis cell lines. High expression of TGF-beta R II and smad7 in the cell lines with high-metastatic potential showed a conceivable TGF-beta signal pathway independent Smads in the lung cancer, and that might mediate invasion and metastasis of lung cancer.
Insights
Aberrant Smad protein expression is linked to lung cancer development and progression. Specifically, high TGF-beta R II and Smad7 expression in metastatic lung cancer cells suggests a role in invasion and metastasis.
Area of Science:
- Molecular Biology
- Oncology
- Cell Signaling
Background:
- Transforming Growth Factor-beta (TGF-beta) signaling, mediated by Smad proteins, regulates critical cellular processes.
- Dysregulation of the TGF-beta/Smads pathway is implicated in cancer development, progression, invasion, and metastasis.
- Understanding Smad protein roles is crucial for targeting lung cancer therapies.
Purpose of the Study:
- To investigate the expression and localization of key TGF-beta/Smads pathway components in lung cancer.
- To correlate Smad protein expression patterns with lung cancer tumorigenesis and metastatic potential.
Main Methods:
- Immunohistochemistry was employed to analyze TGF-beta R II, Smad2, Smad4, and Smad7 expression.
- Lung cancer tissues (20 specimens) and cell lines (8) were examined.
Main Results:
- Aberrant Smad protein expression was significantly associated with lung cancer tumorigenesis and progression.
- Elevated expression of TGF-beta R II and Smad7 was observed in highly metastatic lung cancer cell lines.
- High TGF-beta R II and Smad7 levels in metastatic cells suggest a potential TGF-beta-independent Smad mechanism driving lung cancer invasion and metastasis.
Conclusions:
- Smad protein dysregulation plays a significant role in lung cancer pathogenesis.
- TGF-beta R II and Smad7 may act independently of the canonical TGF-beta pathway to promote lung cancer metastasis.
- Targeting these Smad proteins could offer novel therapeutic strategies for lung cancer.
